Last reviewed · How we verify

NCT05053438

Evaluating Hunger Manipulation During Feeding Intervention

Completed NA Last updated 28 November 2023
What this trial tests

NA trial testing Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care in Feeding Disorders in 16 participants. Completed in 18 October 2023.

Timeline
1 July 2021
Primary endpoint
18 October 2023
18 October 2023

Quick facts

Lead sponsorEmory University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment16
Start date1 July 2021
Primary completion18 October 2023
Estimated completion18 October 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Emory University

Who can join

Adults 18 Months to 6, any sex, with Feeding Disorders or Feeding and Eating Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to determine to what extent hunger provocation, via rapid weaning from enteral feedings, is acceptable and feasible and to evaluate the effect of this intervention when used in an intensive multidisciplinary feeding intervention (IMFI) model of treatment (standard care), for individuals with Avoidant Food Intake Disorder (ARFID) who are dependent on enteral feedings to meet their daily caloric needs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Feeding Disorders

Currently open trials in the same condition.

Other Emory University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05053438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing